BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 22137918)

  • 1. Co-morbidities in established rheumatoid arthritis.
    Gullick NJ; Scott DL
    Best Pract Res Clin Rheumatol; 2011 Aug; 25(4):469-83. PubMed ID: 22137918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What is the outcome of RA in 2011 and can we predict it?
    Verstappen SM; Symmons DP
    Best Pract Res Clin Rheumatol; 2011 Aug; 25(4):485-96. PubMed ID: 22137919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safe use of antirheumatic agents in patients with comorbidities.
    Makol A; Wright K; Matteson EL
    Rheum Dis Clin North Am; 2012 Nov; 38(4):771-93. PubMed ID: 23137582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of established rheumatoid arthritis with an emphasis on pharmacotherapy.
    Blom M; van Riel PL
    Best Pract Res Clin Rheumatol; 2007 Feb; 21(1):43-57. PubMed ID: 17350543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for cardiovascular disease in rheumatoid arthritis.
    Gabriel SE; Crowson CS
    Curr Opin Rheumatol; 2012 Mar; 24(2):171-6. PubMed ID: 22249350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disease-modifying antirheumatic drugs are associated with a reduced risk for cardiovascular disease in patients with rheumatoid arthritis: a case control study.
    van Halm VP; Nurmohamed MT; Twisk JW; Dijkmans BA; Voskuyl AE
    Arthritis Res Ther; 2006; 8(5):R151. PubMed ID: 16984661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient, disease, and therapy-related factors that influence discontinuation of disease-modifying antirheumatic drugs: a population-based incidence cohort of patients with rheumatoid arthritis.
    Maradit-Kremers H; Nicola PJ; Crowson CS; O'Fallon WM; Gabriel SE
    J Rheumatol; 2006 Feb; 33(2):248-55. PubMed ID: 16358365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Co-morbidity index in rheumatoid arthritis: time to think.
    El Miedany Y
    Clin Rheumatol; 2015 Dec; 34(12):1995-2000. PubMed ID: 26497664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. "5D" Outcome in 52 patients with rheumatoid arthritis surviving 20 years after initial disease modifying antirheumatic drug therapy.
    Capell H; McCarey D; Madhok R; Hampson R
    J Rheumatol; 2002 Oct; 29(10):2099-105. PubMed ID: 12375318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunosuppressive medications and hospitalization for cardiovascular events in patients with rheumatoid arthritis.
    Solomon DH; Avorn J; Katz JN; Weinblatt ME; Setoguchi S; Levin R; Schneeweiss S
    Arthritis Rheum; 2006 Dec; 54(12):3790-8. PubMed ID: 17136752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of nonbiologic disease-modifying antirheumatic drugs and risk of infection in patients with rheumatoid arthritis.
    Lacaille D; Guh DP; Abrahamowicz M; Anis AH; Esdaile JM
    Arthritis Rheum; 2008 Aug; 59(8):1074-81. PubMed ID: 18668604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular risk in rheumatoid arthritis.
    Nurmohamed MT
    Autoimmun Rev; 2009 Jul; 8(8):663-7. PubMed ID: 19393192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment for rheumatoid arthritis and the risk of hospitalization for pneumonia: associations with prednisone, disease-modifying antirheumatic drugs, and anti-tumor necrosis factor therapy.
    Wolfe F; Caplan L; Michaud K
    Arthritis Rheum; 2006 Feb; 54(2):628-34. PubMed ID: 16447241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Co-morbidities in Finnish patients with rheumatoid arthritis: 15-year follow-up.
    Tiippana-Kinnunen T; Kautiainen H; Paimela L; Leirisalo-Repo M
    Scand J Rheumatol; 2013; 42(6):451-6. PubMed ID: 23826623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rheumatoid arthritis.
    Carmona L; Cross M; Williams B; Lassere M; March L
    Best Pract Res Clin Rheumatol; 2010 Dec; 24(6):733-45. PubMed ID: 21665122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Co-morbidity in rheumatoid arthritis.
    Mikuls TR
    Best Pract Res Clin Rheumatol; 2003 Oct; 17(5):729-52. PubMed ID: 12915155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipid profiles in patients with rheumatoid arthritis: mechanisms and the impact of treatment.
    Steiner G; Urowitz MB
    Semin Arthritis Rheum; 2009 Apr; 38(5):372-81. PubMed ID: 18395771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comorbidity in rheumatoid arthritis].
    Albrecht K
    Dtsch Med Wochenschr; 2014 Sep; 139(37):1844-8. PubMed ID: 25181002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of risk factors for periodontal disease in patients with rheumatoid arthritis.
    Gleissner C; Willershausen B; Kaesser U; Bolten WW
    Eur J Med Res; 1998 Aug; 3(8):387-92. PubMed ID: 9707521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cardiovascular comorbidity in rheumatic disease. Does sex play a role?].
    Kung M; Störk S; Angermann CE
    Herz; 2005 Sep; 30(6):512-21. PubMed ID: 16170682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.